Abstract
Pain is a complex disease that usually remains poorly treated or undertreated, especially the neuropathic pain caused by injury to the peripheral or central nervous system. Antagonists of the NMDA receptor complex have emerged as potential drugs for pain management. A strong case is being raised for noncompetitive or uncompetitive antagonists with low-to-moderate affinity and fast on / offset kinetics as drugs with good therapeutic profiles, because of their reduced side effects.
Keywords: excitatory activity, nerve damage, inflammation, ion channels, protein networks, uncompetitive antagonists, synaptic plasticity, drug discovery, pain killers
Mini-Reviews in Medicinal Chemistry
Title: Small Molecules Targeting the NMDA Receptor Complex as Drugs for Neuropathic Pain
Volume: 3 Issue: 7
Author(s): Rosa Planells-Cases, Enrique Perez-Paya, Angel Messeguer, Cristina Carreno and Antonio Ferrer-Montiel
Affiliation:
Keywords: excitatory activity, nerve damage, inflammation, ion channels, protein networks, uncompetitive antagonists, synaptic plasticity, drug discovery, pain killers
Abstract: Pain is a complex disease that usually remains poorly treated or undertreated, especially the neuropathic pain caused by injury to the peripheral or central nervous system. Antagonists of the NMDA receptor complex have emerged as potential drugs for pain management. A strong case is being raised for noncompetitive or uncompetitive antagonists with low-to-moderate affinity and fast on / offset kinetics as drugs with good therapeutic profiles, because of their reduced side effects.
Export Options
About this article
Cite this article as:
Planells-Cases Rosa, Perez-Paya Enrique, Messeguer Angel, Carreno Cristina and Ferrer-Montiel Antonio, Small Molecules Targeting the NMDA Receptor Complex as Drugs for Neuropathic Pain, Mini-Reviews in Medicinal Chemistry 2003; 3 (7) . https://dx.doi.org/10.2174/1389557033487782
DOI https://dx.doi.org/10.2174/1389557033487782 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
RAGE: A Single Receptor for Several Ligands and Different Cellular Responses: The Case of Certain S100 Proteins
Current Molecular Medicine Cerebral Arachidonate Cascade in Dementia: Alzheimers Disease and Vascular Dementia
Current Neuropharmacology New Strategies for Clinical Trials in Autism Spectrum Disorder
Reviews on Recent Clinical Trials Prostaglandin EP Receptor Subtypes Involved in Regulating HCO3- Secretion from Gastroduodenal Mucosa
Current Pharmaceutical Design Modulating the Amyloidogenesis of α-Synuclein
Current Neuropharmacology Application of Chiral α-Monofluorocarbonyl Compounds to Analytical and Medicinal Chemistry
Current Organic Chemistry Agomelatine in the Treatment of Major Depressive Disorder: An Assessment of Benefits and Risks
Current Neuropharmacology Nasal <i>In-situ</i> Gel: An Approach to Enhance Therapeutic Benefits of the Drug
Drug Delivery Letters Second Generation Antipsychotics in Asperger’s Disorder and High Functioning Autism: A Systematic Review of the Literature and Effectiveness of Meta-Analysis.
Current Clinical Pharmacology Metabotropic Glutamate Receptor Dependent Cortical Plasticity in Chronic Pain
Current Neuropharmacology Three Dimensional Analysis of SPECT Images for Diagnosing Early Parkinson’s Disease using Radial Basis Function Kernel − Extreme Learning Machine
Current Medical Imaging Therapeutic Potential of DNA-aptamers Raised Against AGE-RAGE Axis in Diabetes-related Complications
Current Pharmaceutical Design Are Cerebrovascular White Matter Lesions an Early Sign of Vascular Cognitive Impairment and Vascular Dementia?
Vascular Disease Prevention (Discontinued) The Expanding Universe of Neurotrophic Factors: Therapeutic Potential in Aging and Age-Associated Disorders
Current Pharmaceutical Design Preparation of Potent Leptin Receptor Antagonists and Their Therapeutic Use in Mouse Models of Uremic Cachexia and Kidney Fibrosis
Current Pharmaceutical Design Antioxidant Supplements, Genetics and Chemotherapy Outcomes
Current Cancer Therapy Reviews Extraction, Properties, and Applications of Bioactive Compounds Obtained from Microalgae
Current Pharmaceutical Design Meta-analysis of Native Studies as Regards the Effectiveness of Antidepressants on Deficit Syndrome of Schizophrenia: A Systematic Review
Current Psychopharmacology A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of the H<sub>3</sub> Receptor Antagonist, GSK239512 as a Monotherapy in Subjects with Mild-to-Moderate Alzheimer’s Disease
Current Alzheimer Research Fatty Acid Amide Hydrolase: A Potential Target for Next Generation Therapeutics
Current Pharmaceutical Design